文献速递妇科

阴道雌激素治疗在绝经后盆腔器官脱垂女性中的作用:对围手术期结局是否有影响?随机对照试验的系统综述

The Role of Vaginal Oestrogen Therapy in Postmenopausal Women With Pelvic Organ Prolapse: Does It Have Any Impact on Perioperative Outcomes? A Systematic Review of Randomised Controlled Trials.
PubMed 文献 · BJOG · 2025-06-24

该系统综述纳入10项随机对照试验共709例患者,评估围手术期阴道雌激素治疗对绝经后盆腔器官脱垂手术结局的影响。阴道雌激素对阴道成熟指数、阴道厚度和术者对组织质量的感知有积极影响,并可能减少术后尿路感染和抗生素使用,但对性功能、手术难度、手术失败率或脱垂复发无显著影响。现有证据有限,需进一步标准化试验。

要点

  • 阴道雌激素可改善阴道成熟指数、阴道厚度及术者对组织质量的感知。
  • 阴道雌激素可能减少术后尿路感染和抗生素使用。
  • 对性功能、手术难度、手术失败率或脱垂复发无显著影响。

核心结论

  • 阴道雌激素在改善阴道组织质量、减少尿路感染和抗生素使用方面有潜在益处,但当前证据有限,需进一步标准化试验以得出更明确结论。

研究设计与样本

  • 系统综述,检索PubMed、MEDLINE、ClinicalTrials.gov和Embase从建库至2024年12月31日,仅纳入同行评议的英文随机对照试验,最终分析10项研究共709例患者。

主要发现

  • 阴道雌激素对阴道成熟指数、阴道厚度和术者对组织质量的感知有积极影响。
  • 阴道雌激素可能减少术后尿路感染和抗生素使用。
  • 对性功能、手术难度、手术失败率或脱垂复发无显著影响。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 当前证据有限。
  • 需进一步标准化试验以得出更明确结论。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Pelvic organ prolapse (POP) affects up to 50% of postmenopausal women, negatively impacting sexual function and quality of life. While surgery remains the primary treatment, increasing attention has been given to perioperative vaginal oestrogen therapy and its potential impact on surgical outcomes. OBJECTIVES: This systematic review aims to evaluate the latest evidence on the role of vaginal oestrogen therapy in perioperative management and its impact on surgical outcomes in postmenopausal women with POP. SEARCH STRATEGY: A systematic literature search was performed across PubMed, MEDLINE, ClinicalTrials.gov and Embase from inception to December 31, 2024. No geographic restrictions were imposed and only peer-reviewed English-language studies were included. SELECTION CRITERIA: Only prospective, randomised controlled trials (RCT) examining perioperative vaginal oestrogen therapy in postmenopausal women undergoing POP surgery were included. DATA COLLECTION AND ANALYSIS: Study identification and data extraction were independently performed by two and three authors, respectively. The Cochrane Collaboration's tool was used to assess bias, with disagreements resolved by a fourth reviewer. MAIN RESULTS: Ten studies involving 709 patients were analysed. Vaginal oestrogen therapy showed a positive effect on Vaginal Maturation Index (VMI), vaginal thickness and surgeon's perception of tissue quality. It also appeared to reduce postoperative urinary tract infections (UTIs) and antibiotic use. However, no significant impact on sexual function, surgical ease, rates of surgical failure or POP recurrence was observed. CONCLUSIONS: Despite potential benefits in enhancing vaginal tissue quality and reducing UTIs and antibiotic use, current evidence is limited. Further standardised trials are needed for more definitive conclusions.

来源:BJOG,查看原文。版权归原作者所有。

引用

  1. Sicilia G, Vitale SG, D'Alterio MN, et al. The Role of Vaginal Oestrogen Therapy in Postmenopausal Women With Pelvic Organ Prolapse: Does It Have Any Impact on Perioperative Outcomes? A Systematic Review of Randomised Controlled Trials. BJOG. 2025. PMID: 40552437. doi:10.1111/1471-0528.18260

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。